alexa Delusional Misidentification Syndrome with Response to Donepezil and Behavioral Intervention in a Patient with Dementia | OMICS International
ISSN: 2329-8847
Journal of Aging Science
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Delusional Misidentification Syndrome with Response to Donepezil and Behavioral Intervention in a Patient with Dementia

Muhammad Ubaid Hafeez1#, Katherine T. Mun2#, Haris Kamal1 and Kinga Szigeti1*

1Department of Neurology, The State University of New York at Buffalo, USA

2Department of Psychiatry, The State University of New York at Buffalo, USA

#The first two authors contributed equally to the manuscript

*Corresponding Author:
Kinga Szigeti
Department of Neurology, University at Buffalo
100 High Street, E2, Buffalo
New York, 14203, USA
Tel: (716) 859-3539
E-mail: [email protected]

Received date: June 11, 2017; Accepted date: July 17, 2017; Published date: July 21, 2017

Citation: Hafeez MU, Mun KT, Kamal H, Szigeti K (2017) Delusional Misidentification Syndrome with Response to Donepezil and Behavioral Intervention in a Patient with Dementia. J Aging Sci 5:181. doi:10.4172/2329-8847.1000181

Copyright: © 2017 Hafeez MU, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Aging Science

Abstract

Introduction: Delusional Misidentification Syndrome (DMS) encompasses a group of disorders in which a person persistently believes the identity of people, places, or objects are altered. Historically, described in psychotic disorders, DMS prevalence is 15.8% in Alzheimer's disease (AD) and 16.6% in dementia with Lewy bodies (DLB). We present a case of DMS in a patient with dementia that incorporates elements of mirrored self-misidentification and phantom boarder syndrome and therapeutic response to a combination of a behavioral intervention and donepezil.

Case: 75-year-old white female presented with a four months history of DMS and visual hallucinations. Patient perceived her own reflection in picture glass as an older lady who was trying to steal her "boyfriends." Her "boyfriends" were three pictures of soldiers in her apartment. MMSE was 27/30 (WORLD) and 23/30 (Serial 7s). MRI showed biparietal and right hippocampal atrophy. NPT showed impaired language, spatial abilities, memory, and executive control. She scored <1 percentile on category word fluency, judgement of line orientation, raw complex figures and Beery VMI. Patient was diagnosed with probable AD, using NINCDS-ADRDA and findings on neuropsychological testing (NPT) and MRI. DLB was excluded using McKeith's criteria. After a failed trial of risperidone, she received donepezil and family was instructed to remove photographs. MMSE stable with resolution of the mirrored selfmisidentification at 4 months follow up.

Conclusion: Patient's poor response to risperidone is consistent with previous studies suggesting limitations of antipsychotic treatment for psychotic symptoms in AD. Removal of potential symptom trigger along with an acetylcholinesterase inhibitor resulted in remission for up to 4 months. The potentiating effect of donepezil on the cholinergic component of the visuo-amygdaloid pathway/dorsal visual pathway may account for these changes.

Keywords

Delusional misidentification syndrome; Dementia; Poserior cortical atrophy; Alzheimer's disease; Cholinesterase inhibitors

Introduction

Delusional misidentification syndromes (DMS) encompass a group of delusional disorders in which patients persistently believe that people, places, objects, or events have somehow been altered. They are usually associated with schizophrenia spectrum, but also reported with organic disorders like dementias, epilepsy, traumatic brain injury, subarachnoid hemorrhage [1] and stroke [2]. The prevalence in Alzheimer’s dementia (AD) and dementia with Lewy Bodies (DLB) is estimated at 16%, with the prevalence somewhat higher in DLB [3]. We present a case that incorporated elements of mirrored selfmisidentification (delusion that one’s reflection in the mirror is another person) and phantom boarder (delusion that someone uninvited is living in one’s house), resolved with combination of behavioral intervention and donepezil.

Case Report

Ms. H was a 75 year old female who presented with a four months history of visual hallucinations (VH) and DMS. She reported living in her apartment with 3 boyfriends and recently noticed an older woman trying to steal the boyfriends from her. Ms. H called the police several times because of the older woman. According to her daughter, the “boyfriends” were photographs of three soldiers, pictured from waist up (no legs visible in the pictures). Ms. H believed that those men lost their legs in a war. She carried those pictures around, believing they men couldn’t walk and needed her help. She acknowledged that they were photographs but believed that they had material bodies with certain needs. One of the pictures were of her late husband in his youth but patient didn’t acknowledge it. Ms. H also reported that she could see the reflection of the older woman trying to climb onto her boyfriends which was in fact her own reflection in the glass of picture frames. She claimed that old woman in reflection always wore the same jewelry and clothes as her which she must had stolen from her as well.

She scored 27 on MMSE WORLD and 23 with Serial 7s. Neuropsychological testing (NPT) showed impaired language, spatial abilities, immediate memory and executive control (Table 1). Dalyed recall was borderline abnormal. MRI showed bi-parietal, occipital and right hippocampal atrophy (Figures 1-3). She presented to us after a failed trial of risperidone. Given that her presentation and workup was more consistent with AD, she was started on donepezil 5 mg, titrated to 10 mg/day. The family was also instructed to put the photographs away to remove the presumed trigger.

aging-science-sagittal-views

Figure 1: T1 sagittal views demonstrating bi-parietal atrophy.

aging-science-axial-views

Figure 2: T1 axial views demonstrating bi-parietal atrophy.

aging-science-brain-volume

Figure 3: T2 coronal views demonstrating the loss of brain volume.

Cognitive Test Description (Raw scores & Interpretation) Percentiles adjusted for age Percentiles adjusted for age, sex & Education Interpretation
MMSE Used as baseline to assess general cognitive ability World 27, serial seven 23 - - -
NAART IQ Estimated premorbid intelligence 110 - - High Average
Boston naming test Confrontational word retrieval 46 5 - Borderline
CIFA letter word fluency Language and academic skills 26 42 58 Normal
CIFA category word fluency Language and academic skills 21 1 1 Defect
Beery Developmental test of visual-motor integration Visual-motor construction & Integration 18 1 - Defect
Clock drawing test Visual-motor construction, visual-motor planning and organization - - - -
Benton judgement of
line orientaion test
Line and angle discrimintaion 0 <1 - Defect
Benton facial recognition test Facial recgonition, Capgras-like visual decomposition of face 17 - - Defect
Rey complex figure copy Visual-motor construction and Organization 5 <1 <1 Defect
Hopkins verbal learnig test (trials 1-3) Verbal short term memory 14 8 14 Borderline
Hopkins verbal learning test (delayed recall) delayed verbal memory and recall (delay 20-25 mins) 6 24 34 Normal
Hopkins verbal learning test retention (%) Verbal memory retention 100 84 86 Normal
Hopkins delayed recognition index - 6 2 4 Borderline
WMS-R logical memory
trial-1
Logical learning and memory 11 2 2 Defect
WMS-R logical memory
trial-2
Delayed logical memory and recall (delay: 20-25 mins) 9 8 12 Borderline
Wms-R Visual Reproduction
Trial-1
Visual learning and memory 22 18 21 Normal
Wms-R Visual Reproduction
Trial-2
Delayed visual memory and recall (delay: 20-25 mins) 3 10 12 Borderline
Wais iii digit span forward Short-term memory, working memory and recall 5 16 18 Normal
Wais iii digit span backward Short-term memory, working memory and recall 3 5 4 Borderline
Wais iii total digit span (forward + backward) - 8 7 7 Borderline
Trail making test-a
(secs to complete)
Visual attention and executive control 49 34 38 Normal
Trial making test-b
(secs to complete)
Visual attention and executive control d/c - - Defect
DKEFS sorting test -
correct sorts
Verbal and spatial concept formation and executive control 2 2 - Defect
DKEFS sorting test -
description score
Verbal and spatial concept formation and executive control 6 2 - Defect
DKEFS sorting test
- repeated sorts
Verbal and spatial concept formation and executive control 1 50 - Normal
Geriatric depression scale - 7 - - Mild
Purpose in life scale - 3 - - Average
Neuropsychiatric inventory - 32 - - Moderate
Lawton brody adl/iadl,
Self report
Self-reported activities of daily living 2 8 7 Borderline
Lawton brody adl/iadl,
infromant report
Informant reported activities of daily living 4 3 3 Borderline

Table 1: Neuropsychiatric test results.

At 4 months follow-up, she demonstrated marked improvement stating, “That old lady is finally gone!” The photographs were put back after 2 weeks, as per her request, without recurrence of DMS. She still acknowledged the presence of her soldier friends but it was not distressful. Her MMSE remained stable.

Discussion

Patient was diagnosed with probable AD, using NINCDS-ADRDA which was further supported on NPT and MRI [4]. Patient did not meet the Mckeith’s Criteria for probable DLB as no cognitive fluctuations, parkinsonism or REM sleep behavioral disorder were observeded [5]. Possible DLB still remained in differential given prominent visuospatial deficits, visual hallucinations (VH), exectutive dysfunction and the fact that AD and DLB frequently overlap. Further diagnositic modalities including transcranial magnetic stimulation study Posterior cortical atrophy (PCA) variant was also a consideration given prominent space and object percepion deficits, constructional dysparaxia seen on NPT and marked parieto-occipital and temporal atrophy seen on MRI. However, our patient lacked other frequently seen PCA features including Balint's syndrome (simultanagnosia, oculomotor apraxia, optic ataxia) or Gerstmann's syndrome (acalculia, agraphia, finger agnosia, left/right disorientation) [6].

Neuroanatomical correlations for VH and DMS include right mesiotemporal atrophy or involvement of ventral and dorsal visual streams. Ismail Z., in his review reported that delusions in AD are predominantly a right hemispheric phenomenon with medial temporal lobes specifically involved in DMS [7]. A disconnection from right temporo-limbic regions may result into lack of insight into the visual stimuli and hence the wrong emotional responses attached to them.

The involvement of ventral (occipito-temporal) and dorsal (occipito-parietal) visual streams can also explain these symptoms. These pathways, through connections to the limbic system, are involved in processing facial recognition and generating affective responses, based on the familiarity to the stimulus. Any disruption along these pathways can lead to a false interpretation of the visual stimulus [8]. Reeves et al. suggested a role of ventral visual pathway based on the poor performance on rapid visual processing tests that have documented association with these pathways [9]. Diffusion tensor imaging studies also showed the involvement of an indirect occipito-temporal pathway (inferior longitudinal fasciculus) [10]. Furthermore, post-mortem studies have shown increased tax burden along these pathways as well as in right hippocampal and parahippocampal regions [11-13].

Several studies have described the role of cholinesterase inhibitors (ChEI) in managing neuropsychiatric symptoms of AD, DLB, and Parkinon’s disease dementia (PDD) [14-16]. ChEI have also been reported to be beneficial in managining DMS in cases of DLB [17], vascular dementia [18] and PDD [19]. In addition, antipsychotics and simple behavioral interventions have been used for DMS with some success, although antipsychotics are not without risk and side effects in such patients [20,21] (see Table 2). In our case, a combination of behavioral modification with donepezil was effective. Further doubleblind studies are needed to evaluate the role of ChEI in treating DMS associated with neurodegeneration.

Study # of Patients DMSs Type Underlying Pathology Treatment Outcome
Gil-Ruiz, et al. 1 Mirror Sign Probable DLB Behavioral Intervention Mirror Sign replaced by Imposters/ another DMS
Oulis P, et al. 1 Capgras Paranoid Schizophrenia complicated by Vascular Dementia Donepezil,
Olanzapine
Resolved
Peritogiannis V, et al. 1 Capgras Vascular Dementia Donepezil Resolved
Reimers, et al. 2 Capgras DLB Donepezil Resolved
Roane, et al. 3 Capgras,
Reduplication
PDD Clozapine Resolved in 2/3 cases
Shiotsuki 1 Capgras PDD Failed trial with Donepezil,
Increased dose of levodopa/ carbidopa
 
Sutton 1 Capgras Dementia NOS Quetiapine Improved
Marantz 1 Capgras DLB   Spontaneous resolution with worsening of the disease
Pagonabarraga J, et al. 5   PDD A) Quetiapine in 3 patients. B) Ziprasidone in 1 patients C) Riviastigmine initiated in 1 patient 4/5 patients were already on it Improvement with Quetiapine in 2/3 patients. Improvement with Ziprasidone 1/1 patient. Marked improvement was observed in the one in which therapy was initiated with rivastigmine

Table 2: Cases reporting successful management of DMS in neurodegenerative disorders

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 380
  • [From(publication date):
    August-2017 - Dec 13, 2017]
  • Breakdown by view type
  • HTML page views : 345
  • PDF downloads : 35
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]ne.com

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version